OTC Triptans in Azerbaijan

April 2013 | 16 pages | ID: OE1333C8076EN
Euromonitor International Ltd

Abstracts

In 2012 all drugs classified as triptans remained Rx in Azerbaijan. Doctors can prescribe triptans to patients suffering from migraines if this diagnosis is approved.

Euromonitor International's OTC Triptans in Azerbaijan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the OTC Triptans market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

OTC TRIPTANS IN AZERBAIJAN
Euromonitor International
April 2013

Trends
Executive Summary
Consumer Health Sees Higher Growth in 2012 Than During the Review Period
Self-medication Still Strong, Affecting Both Rx and OTC Markets
Multinational Companies Lead
Parapharmacies/drugstores Is the Leading Distribution Channel
Stronger Forecast Constant Value Growth
Key Trends and Developments
Improved Economy Positively Affects the Consumer Health Market
Fake Medicines Still Exist, But Are Decreased To A Minimum
Healthier Lifestyles Boost Sales of Vitamins and Dietary Supplements
Market Indicators
  Table 1 Consumer Expenditure on Health Goods and Medical Services 2007-2012
  Table 2 Life Expectancy at Birth 2007-2012
Market Data
  Table 3 Sales of Consumer Health by Category: Value 2007-2012
  Table 4 Sales of Consumer Health by Category: % Value Growth 2007-2012
  Table 5 Consumer Health Company Shares 2008-2012
  Table 6 Consumer Health Brand Shares 2009-2012
  Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  Table 9 Forecast Sales of Consumer Health by Category: Value 2012-2017
  Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
Summary 1 Research Sources